As previously reported, BofA analyst Bill Sills initiated coverage of Hinge Health (HNGE) with a Buy rating and $42 price target calling it the “digital physical therapy leader.” The firm thinks Hinge is well positioned to continue capturing share of an $18.5B addressable market due to “formidable” competitive advantages such as a large customer base of 2,250 companies, the depth and breadth of its offerings, its proprietary motion-tracking technology, and its 50-plus healthcare partners, including five of the largest health plans, the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HNGE:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue